Health

Live webcast today: Harnessing the power of data to improve health

Today the Department of Health and Human Services and the Institute of Medicine are holding their second forum to discuss how health data can be used to support healthcare systems and patients in informed decision making.

More than 40 companies will be participating, and the featured speakers include Aneesh Chopra, US CTO; Tim O'Reilly, O’Reilly Media; Matt Miller, NPR; Harvey Fineberg, IOM President; Todd Park, HHS CTO. » Read more

1 Comment

Opening the field of neurobiological research

What does it take to find a cure for Alzheimer’s? Can we spare returning soldiers from post-traumatic stress disorder?

The moon shot is on collaboration and sharing. And just as in the moon race, the challenge is far too great for a single group to undertake it alone.
» Read more

0 Comments

Socrates, social media and the new dialectic

"If I tell you that this is the greatest good for a human being, to engage every day in arguments about virtue and the other things you have heard me talk about, examining both myself and others, and if I tell you the unexamined life is not worth living for a human being, you will be even less likely to believe what I am saying. But that's the way it is."
- Passage from Socrates' famous speech at his trial.

0 Comments

Liquid data and the health information economy: Is 2011 finally the year?

What a difference three years makes. It seems quaint now that in the 2008 NEJM there were concerns raised about the flow of health information onto the web. Back then there was but a faint trickle of what could be entered, mostly by hand, and accessed on the web. Before HITECH and health care reform, exchanging health data online seemed blasphemous to many hospitals, patients, and physicians alike.

Fast forward to today and where we are now: » Read more

4 Comments

Open health and medical gag orders

Last week a friend of mine posted on Facebook, “I need a new lawnmower. Any opinions on what I should get?”

She received several responses. One person suggested a goat. Another posted a picture of an attractive shirtless man with bulging muscles gleaming with sweat as he worked in the yard. But others identified the pros and cons of various lawnmower brands for her. Based on those comments and reviews, she went with a Fiskar's momentum reel mower because it "won't need to be repaired."
» Read more

2 Comments

Is the future of health patient-driven?

People often share more about their health and medical experiences on Facebook than they do with their own doctors. They talk about their experiences with illness, their symptoms, the medications they're taking, the side effects, what works, what doesn't, even various treatment options.

It turns out this online health chatter can be a lifesaver.
» Read more

4 Comments

Can social communities transform clinical trials?

Big pharma is one of the main scapegoats for the steeply rising costs of medical care. This might make sense when you learn how staggering the pricetag on necessary processes—like clinical trials—can be.

According to the Pharmaceutical Research and Manufacturers of America (PhRMA), the U.S. pharmaceutical industry’s advocacy group, it costs $1.3B (in 2005 dollars) to bring a new drug to market. » Read more

0 Comments

Open source biology

Could patent restrictions in biotech be compromising millions' health, safety, and standards of living when we should be benefiting from new diagnostic tests or improved medicines? » Read more

1 Comment

Collaboration holds greatest potential for health innovation

Many of us, at some point in our lives, have had to deal with a variety of different healthcare professionals for an episode of care. Perhaps your primary physician has referred you to a specialist, or the ER doctor required you to see your primary physician for follow-up, or you've been admitted to the hospital from the ER.

When going from one healthcare provider to another, a patient’s health information—including the symptoms, test results, diagnosis, treatment plans, medications, allergies—can often be lacking, missing, contradictory, or just confusing.
» Read more

0 Comments

Is the future of Pharma open source?

What do you do when the profitable market for a drug is small, but the medical need is huge?

You open source it. » Read more

1 Comment